Xtant Medical Holdings (XTNT) EPS (Weighted Average and Diluted) (2010 - 2025)
Xtant Medical Holdings (XTNT) reported EPS (Weighted Average and Diluted) of $0.0 for Q4 2025, up 101.9% year-over-year from $0.0 in Q4 2024, and down 96.2% on a QoQ basis from $0.01 in Q3 2025.
Xtant Medical Holdings (XTNT) has 16 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.0 in Q4 2025.
- Quarterly EPS (Weighted Average and Diluted) rose 101.9% year-over-year to $0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $0.0 (up 100.32% YoY) and the FY2025 annual result came in at $0.03, up 127.62% from the prior year.
- EPS (Weighted Average and Diluted) fell to $0.0 in Q4 2025 per XTNT's latest filing, from $0.01 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.07 in Q3 2023 and bottomed at -$0.04 in Q3 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.02 (2021), against an average of -$0.01.
- The widest annual swing landed in 2022, when EPS (Weighted Average and Diluted) tumbled 8305.06%; it then jumped 333.33% in 2023.
- Tracing XTNT's EPS (Weighted Average and Diluted) over 5 years: stood at -$0.03 in 2021, then jumped by 33.33% to -$0.02 in 2022, then tumbled by 50.0% to -$0.03 in 2023, then jumped by 33.33% to -$0.02 in 2024, then surged by 101.9% to $0.0 in 2025.
- Per Business Quant, the three latest XTNT EPS (Weighted Average and Diluted) figures stand at $0.0 (Q4 2025), $0.01 (Q3 2025), and $0.02 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Xtant Medical Holdings | 64.46 Mn | 47.14 Mn | 17.75 Mn | 0.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.04 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.03 |
| Dec 31, 2023 | -0.03 |
| Sep 30, 2023 | 0.07 |
| Jun 30, 2023 | -0.02 |
| Mar 31, 2023 | -0.02 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | -0.03 |
| Jun 30, 2022 | -0.02 |
| Mar 31, 2022 | -0.03 |
| Dec 31, 2021 | -0.03 |
| Sep 30, 2021 | -0.02 |
| Jun 30, 2021 | -0.01 |
| Mar 31, 2021 | 0.00 |
| Dec 31, 2020 | 0.23 |
| Sep 30, 2020 | -0.10 |
| Jun 30, 2020 | -0.19 |
| Mar 31, 2020 | -0.19 |
| Dec 31, 2019 | -0.13 |
| Sep 30, 2019 | -0.14 |
| Jun 30, 2019 | -0.15 |
| Mar 31, 2019 | -0.21 |
| Dec 31, 2018 | -4.78 |
| Sep 30, 2018 | -0.24 |
| Jun 30, 2018 | -0.38 |
| Mar 31, 2018 | -0.70 |
| Dec 31, 2017 | -18.82 |
| Sep 30, 2017 | -5.62 |
| Jun 30, 2017 | -6.43 |
| Mar 31, 2017 | -3.87 |
| Dec 31, 2016 | -17.22 |
| Sep 30, 2016 | -0.40 |
| Jun 30, 2016 | -0.37 |
| Mar 31, 2016 | -0.47 |
| Dec 31, 2015 | 1.46 |
| Sep 30, 2015 | -0.64 |
| Jun 30, 2015 | -0.41 |
| Mar 31, 2015 | -0.62 |
| Dec 31, 2014 | -0.50 |
| Sep 30, 2014 | -0.19 |
| Jun 30, 2014 | -0.35 |
| Mar 31, 2014 | -0.77 |
| Dec 31, 2013 | -2.62 |
| Sep 30, 2013 | -0.08 |
| Jun 30, 2013 | -0.55 |
| Mar 31, 2013 | -0.04 |
| Dec 31, 2012 | -0.11 |
| Sep 30, 2012 | -0.06 |
| Jun 30, 2012 | 0.02 |
| Mar 31, 2012 | -0.03 |
| Dec 31, 2011 | -0.11 |
| Sep 30, 2011 | -0.08 |
| Jun 30, 2011 | -0.01 |
| Mar 31, 2011 | 0.11 |
| Dec 31, 2010 | -0.19 |
| Sep 30, 2010 | -0.26 |
| Jun 30, 2010 | -0.07 |